Related Experiment Video
Updated: May 27, 2026

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
Immune Cell Infiltration and Key Gene Identification in Alzheimer's Disease and Sleep Deprivation
Liang Yanchao1, Li Yuchen1,2, Xiang Huan1,2
1Department of Neurosurgery, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, 150001, P.R. China.
Introduction:
Alzheimer's disease (AD) is a progressive neurodegenerative disorder marked by Amyloid-β plaques and neurofibrillary tangles. Disrupted circadian rhythms are common in AD and may worsen cognitive decline and psychological symptoms. The link between sleep deprivation and Alzheimer's risk remains unclear. This study aimed to identify potential diagnostic markers for Alzheimer's and sleep deprivation, focusing on the role of immune cell infiltration in disease progression.
Materials And Methods:
We examined AD expression data from the GEO database and sleep deprivation( SD)-related data from GeneCards. Using LIMMA on the GSE15222 dataset, we found 209 DEGs, analyzed them with four machine learning algorithms, and identified four Hub genes. We validated these findings with the GSE33000 dataset. CIBERSORT was employed to analyze 22 immune cell features, and Spearman correlation was used to assess the link between diagnostic markers and immune cells.
Results:
AD and SD were linked to immune microenvironment changes. Initially, 1568 potential key genes were identified, and Venn analysis revealed 209 overlapping regions. Machine learning validated four key genes, confirming their high predictive accuracy. Significant differences in immune cell expression were found in AD samples, and correlation analysis showed CIT, FASN, ELK1, and GFAP were significantly associated with various immune cells.
Conclusion:
CIT, FASN, ELK1, and GFAP are key genes linked to pathology progression in AD and SD within the immune microenvironment. Identifying molecular subgroups may offer new perspectives for personalized Alzheimer's treatment.
More Related Videos
08:44Electrocorticographic Recording of Cerebral Cortex Areas Manipulated Using an Adeno-Associated Virus Targeting Cofilin in Mice
Published on: February 21, 2021
04:22Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease
Published on: May 20, 2024